50 results on '"de Witte, Lot D"'
Search Results
2. Long-term effects of prenatal infection on the human brain: a prospective multimodal neuroimaging study
3. Exploring peripheral biomarkers of response to simvastatin supplementation in schizophrenia
4. Increased postpartum anxiety symptoms after perinatal SARS-CoV-2 infection in a large, prospective pregnancy cohort in New York City
5. Lower fractional anisotropy without evidence for neuro-inflammation in patients with early-phase schizophrenia spectrum disorders
6. Gene expression profiling of monocytes in recent-onset schizophrenia
7. Antidepressants as a potential candidate to reduce microglia activation in neurodegenerative diseases. A systematic review and meta-analysis of preclinical studies
8. New insights into the genetic etiology of Alzheimer’s disease and related dementias
9. Human microglial models to study HIV infection and neuropathogenesis: a literature overview and comparative analyses
10. Diagnostic model development for schizophrenia based on peripheral blood mononuclear cell subtype-specific expression of metabolic markers
11. Transcriptomic and functional analysis of Aβ1-42 oligomer-stimulated human monocyte-derived microglia-like cells
12. Genetic analysis of the human microglial transcriptome across brain regions, aging and disease pathologies
13. The effect of prednisolone on symptom severity in schizophrenia: A placebo-controlled, randomized controlled trial
14. A characterization of the molecular phenotype and inflammatory response of schizophrenia patient-derived microglia-like cells
15. Fully defined human pluripotent stem cell-derived microglia and tri-culture system model C3 production in Alzheimer’s disease
16. Cannabinoids and psychotic symptoms: A potential role for a genetic variant in the P2X purinoceptor 7 (P2RX7) gene
17. The association between schizophrenia and the immune system: Review of the evidence from unbiased ‘omic-studies’
18. Microglial activation in schizophrenia: Is translocator 18 kDa protein (TSPO) the right marker?
19. Cerebrospinal fluid abnormalities in first- and multi-episode schizophrenia-spectrum disorders: impact of clinical and demographical variables
20. B-cells and schizophrenia: A promising link or a finding lost in translation?
21. Neurons and glial cells in bipolar disorder: A systematic review of postmortem brain studies of cell number and size
22. Liprin alfa 2 gene expression is increased by cannabis use and associated with neuropsychological function
23. The effect of SARS-CoV-2 infection and vaccination on Th17 and regulatory T cells in a pregnancy cohort in NYC.
24. Association between doxycycline use and long-term functioning in patients with schizophrenia.
25. Transcriptomic and morphological maturation of human astrocytes in cerebral organoids.
26. Human microglia regional heterogeneity and phenotypes determined by multiplexed single-cell mass cytometry
27. Single-cell mass cytometry of microglia in major depressive disorder reveals a non-inflammatory phenotype with increased homeostatic marker expression
28. The association between antibodies to neurotropic pathogens and bipolar disorder: A study in the Dutch Bipolar (DB) Cohort and meta-analysis
29. Microglia in post-mortem brain tissue of patients with bipolar disorder are not immune activated
30. DNA methylation changes related to nutritional deprivation: a genome-wide analysis of population and in vitro data
31. Genetic liability for schizophrenia predicts risk of immune disorders
32. Microglia innately develop within cerebral organoids
33. Characterization of macrophages from schizophrenia patients
34. Shock and kill within the CNS: A promising HIV eradication approach?
35. Glioblastoma-derived extracellular vesicles modify the phenotype of monocytic cells
36. Efficacy of Anti-inflammatory Agents to Improve Symptoms in Patients With Schizophrenia: An Update
37. Exposure to the Amino Acids Histidine, Lysine, and Threonine Reduces mTOR Activity and Affects Neurodevelopment in a Human Cerebral Organoid Model.
38. Characterization of HIV-1 Infection in Microglia-Containing Human Cerebral Organoids.
39. Contribution of Age, Brain Region, Mood Disorder Pathology, and Interindividual Factors on the Methylome of Human Microglia.
40. DNA methylation differences in cortical grey and white matter in schizophrenia.
41. Childhood Adversity Is Associated With Increased KITLG Methylation in Healthy Individuals but Not in Bipolar Disorder Patients.
42. Are infectious agents involved in the pathogenesis of postpartum psychosis?
43. Microglia-mediated synaptic pruning as a key deficit in neurodevelopmental disorders: Hype or hope?
44. Atlas of genetic effects in human microglia transcriptome across brain regions, aging and disease pathologies.
45. Absence of N-Methyl-D-Aspartate Receptor IgG Autoantibodies in Schizophrenia: The Importance of Cross-Validation Studies.
46. Characterization of HIV variants from paired Cerebrospinal fluid and Plasma samples in primary microglia and CD4+ T-cells.
47. Increased number of T-lymphocytes in post-mortem brain tissue of patients with schizophrenia.
48. Telomere quantification in frontal and temporal brain tissue of patients with schizophrenia.
49. No neuronal autoantibodies detected in plasma of patients with a bipolar I disorder.
50. Association of DNA methylation marks in the stress response regulating gene KITLG to schizophrenia and bipolar disorder.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.